These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3261115)

  • 21. [Cerebral glucose metabolism in autistic children. Study and positron emission tomography].
    De Volder AG; Bol A; Michel C; Cogneau M; Goffinet AM
    Acta Neurol Belg; 1988; 88(2):75-90. PubMed ID: 3260437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain metabolism in mitochondrial encephalomyopathy: a PET study.
    De Volder A; Ghilain S; de Barsy T; Goffinet AM
    J Comput Assist Tomogr; 1988; 12(5):854-7. PubMed ID: 3262636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of blood flow on the positron-emission tomographic determination of substrate transport rates.
    Holden JE
    Circulation; 1985 Nov; 72(5 Pt 2):IV72-6. PubMed ID: 3876895
    [No Abstract]   [Full Text] [Related]  

  • 24. Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
    Blomqvist G; Stone-Elander S; Halldin C; Roland PE; Swahn CG; Haaparanta M; Solin O; Lindqvist M; Widén L
    Acta Radiol Suppl; 1991; 376():171-2. PubMed ID: 1666769
    [No Abstract]   [Full Text] [Related]  

  • 25. Methodologic factors affecting PET measurements of cerebral glucose metabolism.
    Jagust WJ; Budinger TF; Huesman RH; Friedland RP; Mazoyer BM; Knittel BL
    J Nucl Med; 1986 Aug; 27(8):1358-61. PubMed ID: 3488379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tomographic mapping of human cerebral metabolism: normal unstimulated state.
    Mazzilotta JC; Phelps ME; Miller J; Kuhl DE
    Neurology; 1981 May; 31(5):503-16. PubMed ID: 6972012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral glucose metabolism in the course of subacute sclerosing panencephalitis.
    Huber M; Herholz K; Pawlik G; Szelies B; Jürgens R; Heiss WD
    Arch Neurol; 1989 Jan; 46(1):97-100. PubMed ID: 2783367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of percent thresholding on the extraction of [18F]fluorodeoxyglucose positron emission tomographic region-of-interest data.
    Rottenberg DA; Moeller JR; Strother SC; Dhawan V; Sergi ML
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):A83-8. PubMed ID: 1997493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography in dementia.
    Friedland RP
    Semin Neurol; 1989 Dec; 9(4):338-44. PubMed ID: 2701778
    [No Abstract]   [Full Text] [Related]  

  • 30. Brain dopaminergic system studied in patients with dystonia using positron emission tomography.
    Leenders KL; Quinn N; Frackowiak RS; Marsden CD
    Adv Neurol; 1988; 50():243-7. PubMed ID: 3261116
    [No Abstract]   [Full Text] [Related]  

  • 31. The cerebral metabolic landscape in autism. Intercorrelations of regional glucose utilization.
    Horwitz B; Rumsey JM; Grady CL; Rapoport SI
    Arch Neurol; 1988 Jul; 45(7):749-55. PubMed ID: 3260481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The differential diagnosis of depression. Relevance of positron emission tomography studies of cerebral glucose metabolism to the bipolar-unipolar dichotomy.
    Schwartz JM; Baxter LR; Mazziotta JC; Gerner RH; Phelps ME
    JAMA; 1987 Sep; 258(10):1368-74. PubMed ID: 3306000
    [No Abstract]   [Full Text] [Related]  

  • 33. Human cerebral glucose metabolism determined by positron emission tomography: a revisit.
    Brooks RA; Hatazawa J; Di Chiro G; Larson SM; Fishbein DS
    J Cereb Blood Flow Metab; 1987 Aug; 7(4):427-32. PubMed ID: 3497163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolic pathology of the AIDS dementia complex.
    Rottenberg DA; Moeller JR; Strother SC; Sidtis JJ; Navia BA; Dhawan V; Ginos JZ; Price RW
    Ann Neurol; 1987 Dec; 22(6):700-6. PubMed ID: 3501695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of gender on glucose utilization rates in healthy humans: a positron emission tomography study.
    Miura SA; Schapiro MB; Grady CL; Kumar A; Salerno JA; Kozachuk WE; Wagner E; Rapoport SI; Horwitz B
    J Neurosci Res; 1990 Dec; 27(4):500-4. PubMed ID: 2079712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography studies of cerebral glucose metabolism in obsessive compulsive disorder.
    Baxter LR
    J Clin Psychiatry; 1994 Oct; 55 Suppl():54-9. PubMed ID: 7961533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of drug abuse on glucose metabolism.
    London ED
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):S30-6. PubMed ID: 2535418
    [No Abstract]   [Full Text] [Related]  

  • 38. Regional cerebral glucose metabolism in bulimia nervosa.
    Andreason PJ; Altemus M; Zametkin AJ; King AC; Lucinio J; Cohen RM
    Am J Psychiatry; 1992 Nov; 149(11):1506-13. PubMed ID: 1415817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography.
    Alavi A; Reivich M; Ferris S; Christman D; Fowler J; MacGregor R; Farkas T; Greenberg J; Dann R; Wolf A
    Exp Brain Res; 1982; Suppl 5():187-95. PubMed ID: 6983979
    [No Abstract]   [Full Text] [Related]  

  • 40. Regional brain glucose metabolism in neuroacanthocytosis.
    Dubinsky RM; Hallett M; Levey R; Di Chiro G
    Neurology; 1989 Sep; 39(9):1253-5. PubMed ID: 2788833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.